Page last updated: 2024-08-17

apomorphine and Dyskinesia Syndromes

apomorphine has been researched along with Dyskinesia Syndromes in 103 studies

Research

Studies (103)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (50.49)	18.7374
1990's	28 (27.18)	18.2507
2000's	13 (12.62)	29.6817
2010's	10 (9.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD	1
Antonini, A; Jost, WH	1
Chen, J; Chen, S; Lei, W; Li, Y; Luo, C; Ma, Y; OuYang, L; Wu, J; Zhan, M	1
Czarnecka, A; Konieczny, J; Lenda, T; Lorenc-Koci, E	1
Kyuhou, S	1
Gunzler, SA	1
Beal, MF; Bogdanov, M; Burke, RE; Geghman, K; Jackson-Lewis, V; Li, C; Li, Y; Liu, W; Oo, TF; Przedborski, S; Tang, Y; Wang, L; Zhou, C	1
San Luciano, M; Saunders-Pullman, R	1
Colwell, KL; Gidyk, DC; Klein, A; Metz, GA; Shriner, AM; Tatton, NA; Tatton, WG	1
Domanska-Janik, K; Drela, K; Gornicka-Pawlak, EB; Habich, A; Jablonska, A; Janowski, M; Kozlowska, H; Lukomska, B; Sypecka, J	1
Filli, L; Schwab, ME; Weinmann, O; Zörner, B	1
Schnitzler, A; Südmeyer, M; Wojtecki, L	1
Burkhard, PR; Vingerhoets, FJ	1
Fen, L; Guangjian, Z; Jie, F; Rui, G; Xi, J; Yanchao, C; Yong, W	1
Du, RH; Fan, Y; Hu, G; Su, CJ; Xu, XQ	1
Andsberg, G; Arvidsson, A; Kirik, D; Kokaia, Z; Lindvall, O; Lundberg, C; Mandel, RJ	1
Arimura, A; Hiramatsu, Y; Honma, T; Ishibashi, C; Itoh, N; Katsuura, G; Nakazato, H; Okamura, N; Sakaeda, T; Sakaguchi, G; Takahara, Y; Ueda, K; Yagami, T	1
Fairfax, DF; Gupta, SK; Henry, P; Khan, RF; Mishra, RK; N-Marandi, S; Rogoza, RM	1
Axelrod, JD; Barghshoon, S; Chen, CK; Cheyette, BN; Ebert, J; Kovoor, A; Lester, HA; Schwarz, J; Schwarz, S; Seyffarth, P; Simon, MI	1
Comella, C; Widnell, KL	1
Awaya, T; Chiba, K; Matsubara, K; Noda, T; Ogawa, K; Ohtaki, K; Satomi, M; Shimizu, K; Shiono, H; Suno, M; Tasaki, Y; Yamada, T	1
Barone, P; Bonavita, V; De Michele, G; Di Maio, L; Longo, K; Marconi, S; Vitale, C	1
Sundén-Kuronen, B	1
Glassman, HN; Glassman, RB	1
Bédard, P; Boucher, R; Di Paolo, T; Labrie, F	1
Gallitto, G; Giammona, G; Nicoletti, F; Patti, F; Rampello, L; Reggio, A	1
Boschi, G; Launay, N; Rips, R	1
Markova, OF; Stoliarov, GV	1
Albizzati, MG; Bassi, S; Ferrarese, C; Frattola, L; Trabucchi, M	1
Chateau, R; Gaio, JM; Hommel, M; Pellat, J; Perret, J; Pollak, P	1
Bentlage, C; Björklund, A; Nikkhah, G; Olsson, M	1
Brownell, AL; Brownell, GL; Elmaleh, DR; Frim, DM; Hamberg, L; Hantraye, P; Madras, BK; Rosen, BR; Shoup, T; Wullner, U	1
Albani, C; Bächli, E	1
Yoshida, M	1
Chollet, F; Marc-Vergnes, JP; Montastruc, JL; Rascol, A; Rascol, OJ; Sabatini, U	1
Baronti, F; Bramante, L; Monge, A; Ruggieri, S; Stefano, E; Stocchi, F; Viselli, F	1
Esteban Muñoz, J	1
Linazasoro, G	1
Ebert, U; Hedrich, HJ; Löscher, W; Nikkhah, G; Richter, A; Rosenthal, C	1
Bravi, D; Chase, TN; Locatelli, ER; Mouradian, MM; Verhagen Metman, L	1
Marsden, CD; Nordera, G; Stocchi, F	1
Blaney, TJ; Chandonait, SE; Emerich, DF; Lindner, MD; Mullins, TD; Plone, MA; Sherman, SS; Stott, JA; Winn, SR	1
Brouillet, E; Guyot, MC; Hantraye, P; Mary, V; Palfi, S; Peschanski, M; Riche, D; Stutzmann, JM; Wahl, F	1
Albanese, A; Colosimo, C; Merello, M	1
Cozzari, C; Faris, PL; Hartman, BK; Jansen, EM; Low, WC; Solberg, L; Underhill, S; Wilson, S	1
Dougherty, PM; Hallett, M; Lenz, FA; Metman, LV; Reich, SG; Suarez, JI	1
Miranda, M; Villagra, R	1
Benabid, AL; Benazzouz, A; Hoffmann, D; Koudsie, A; Krack, P; Le Bas, JF; Limousin, P; Pollak, P	1
Fiaschi, A; Idone, D; Tezzon, F; Tinazzi, M; Zanette, G	1
Bösch, S; Luginger, E; Poewe, W; Wagner, M; Wenning, GK	1
Corral, C; Darias, V; Expósito-Orta, MA; Lissavetzky, J; Manzanares, I; Martïn Conde, JA; Sánchez-Mateo, CC	1
Ali, MM; Babu, GN; Bawari, M; Misra, UK	1
Büttner, T; Kuhn, W; Müller, T	1
Parkes, JD	1
Tolosa, ES	1
Cools, AR; Van Rossum, JM	1
Marais, C	1
Lai, C; Tolosa, ES	1
Anlezark, GM; Marsden, CD; Meldrum, BS	1
Berrios, N; Marshall, JF	1
Asano, T; Matsumoto, Y; Mimura, Y; Mino, S; Nishimoto, A; Ohmoto, T; Yoshimura, Y	1
Carchedi, F; Casacchia, M; Cerbo, R; Meco, G	1
Kuschinsky, K; Langer, J; Seeber, U; Sontag, KH	1
Barry, VC; Klawans, HL	1
Wolfarth, S	1
Anagnoste, B; Battista, AF; Goldstein, M; Ogawa, M	1
Costall, B; Naylor, RJ	2
Staib, AH; Westermann, KH	2
Bürki, HR; Sayers, AC	1
Calil, HM; Silva, MT	1
Bell-Midura, M; Cotzias, GC; Mendez, JS; Papavasiliou, PS; Tolosa, ES	1
Boucher, R; Dankova, J; Poirier, LJ	1
Klawans, HL; Margolin, DI	1
Crossett, P; Dana, N; Klawans, HL	1
Barbeau, A; Butterworth, RF; Poignant, JC	1
Asper, H; Bürki, HR; Ruch, W; Sayers, AC	1
Crosset, P; Dana, N; Klawans, HL; Margolin, DI	1
Agnoli, A; Carolei, A; Cerbo, R; Meco, G; Ruggieri, S; Zamponi, A	1
Kelly, PH	1
Deffond, D; Durif, F; Eschalier, A; Tournilhac, M	1
Lees, AJ; Merello, M	1
Brooks, DJ; Fernandez, W; Frackowiak, RS; Jenkins, IH; Lees, AJ; Passingham, RE; Playford, ED	1
Caparros-Lefebvre, D; Petit, H; Vermersch, P	1
Bovingdon, M; Hughes, AJ; Lees, AJ; Stern, GM; Webster, R	1
Luquin, MR; Obeso, JA; Vaamonde, J	1
Gerber, R; Gerhardt, SC; Liebman, JM	1
Boyce, S; Clarke, CE; Crossman, AR; Robertson, RG; Sambrook, MA	1
Gessa, GL; Gessa, R; Tagliamonte, A	1
Glick, SD	1
Ungerstedt, U	1
Chase, TN	1
Divac, I	1
Calne, DB; Reid, JL	1
Cotzias, GC; Mena, I; Mendez, J; Papavasiliou, PS	1
Cotzias, GC; Mena, I; Papavasiliou, PS	1
Cotzias, GC	1
Ngai, SH	1
Klawans, HL; Rubovits, R	1
Cotzias, GC; Ginos, JZ; Miller, ST; Tang, LC	1

Reviews

18 review(s) available for apomorphine and Dyskinesia Syndromes

Article	Year
[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2018, Volume: 86, Issue:S 01 Topics: Antiparkinson Agents; Apomorphine; Duodenum; Humans; Infusions, Intravenous; Infusions, Parenteral; Jejunum; Levodopa; Movement Disorders; Parkinson Disease	2018
Apomorphine in the treatment of Parkinson disease and other movement disorders. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:6 Topics: Animals; Apomorphine; Humans; Movement Disorders; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome	2009
Substance abuse and movement disorders. Current drug abuse reviews, 2009, Volume: 2, Issue:3 Topics: Alcoholism; Animals; Apomorphine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Substance Withdrawal Syndrome; Substance-Related Disorders	2009
[Current treatment strategies for Parkinson's disease]. Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:12 Topics: Aged; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Apomorphine; Critical Care; Deep Brain Stimulation; Dementia; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Europe; Female; Humans; Infusion Pumps, Implantable; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Sleep Wake Disorders; Tremor	2011
[Resistance to treatment in movement disorders]. Revue medicale suisse, 2012, May-02, Volume: 8, Issue:339 Topics: Antiparkinson Agents; Apomorphine; Deep Brain Stimulation; Drug Resistance; Essential Tremor; Humans; Levodopa; Movement Disorders; Neurosurgery; Parkinson Disease; Treatment Failure	2012
Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20 Suppl 11 Topics: Apomorphine; Benzophenones; Cabergoline; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Ergolines; Humans; Levodopa; Movement Disorders; Nitriles; Nitrophenols; Parkinson Disease; Tolcapone	2005
[Apomorphine]. Neurologia (Barcelona, Spain), 1995, Volume: 10, Issue:8 Topics: Administration, Sublingual; Apomorphine; Dopamine Agonists; Humans; Injections, Subcutaneous; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease	1995
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias. Clinical neuropharmacology, 1997, Volume: 20, Issue:2 Topics: Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Globus Pallidus; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Stereotaxic Techniques; Thalamus	1997
Clinical usefulness of apomorphine in movement disorders. Clinical neuropharmacology, 1994, Volume: 17, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dystonia; Humans; Huntington Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease	1994
Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease. Advances in neurology, 1999, Volume: 80 Topics: Antiparkinson Agents; Apomorphine; Humans; Injections, Subcutaneous; Movement Disorders; Parkinson Disease; Time Factors	1999
Bromocriptine in the treatment of parkinsonism. Drugs, 1979, Volume: 17, Issue:5 Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior	1979
[Duality of dopaminergic receptors. Pharmacologic and clinical perspectives]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1978, Volume: 54, Issue:13-16 Topics: Animals; Apomorphine; Benzamides; Chorea; Fluorescent Antibody Technique; Guinea Pigs; Haloperidol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Rats; Receptors, Dopamine	1978
On the role of dopamine in the pathophysiology of anorexia nervosa. Journal of neural transmission, 1976, Volume: 38, Issue:2 Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness	1976
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei. Polish journal of pharmacology and pharmacy, 1976, Volume: 28, Issue:5 Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Brain; Carbachol; Caudate Nucleus; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Humans; Movement Disorders; Parasympathetic Nervous System; Parasympathomimetics; Parkinson Disease; Parkinson Disease, Secondary; Rabbits; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Synapses	1976
Monkeys with nigrostriatal lesions effects of monoaminergic drugs. Pharmacology & therapeutics. Part B: General & systematic pharmacology, 1976, Volume: 2, Issue:1 Topics: Amino Acids; Animals; Antiparkinson Agents; Apomorphine; Biogenic Amines; Carboxy-Lyases; Catechol O-Methyltransferase Inhibitors; Chlorocebus aethiops; Corpus Striatum; Drug Interactions; Haplorhini; Harmaline; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Substantia Nigra; Tremor	1976
Drug-induced extrapyramidal disorders. Research publications - Association for Research in Nervous and Mental Disease, 1972, Volume: 50 Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl	1972
Antiparkinsonian drugs: pharmacological and therapeutic aspects. Drugs, 1972, Volume: 4, Issue:1 Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission	1972
Parkinsonism, levodopa, and anesthesia. Anesthesiology, 1972, Volume: 37, Issue:3 Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Catecholamines; Dihydroxyphenylalanine; Dopamine; Fentanyl; Humans; Mice; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Pulmonary Edema; Rats	1972

Trials

9 trial(s) available for apomorphine and Dyskinesia Syndromes

Article	Year
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Adult; Antiparkinson Agents; Apomorphine; Cross-Over Studies; Depression; Double-Blind Method; Female; Humans; Huntington Disease; Infusions, Intravenous; Male; Middle Aged; Mood Disorders; Movement; Movement Disorders; Pilot Projects; Psychiatric Status Rating Scales	2007
Apomorphine and lisuride infusion. A comparative chronic study. Advances in neurology, 1993, Volume: 60 Topics: Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Lisuride; Long-Term Care; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease	1993
The apomorphine test in gait disorders associated with parkinsonism. Clinical neuropharmacology, 1996, Volume: 19, Issue:2 Topics: Aged; Aged, 80 and over; Apomorphine; Female; Follow-Up Studies; Gait; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease	1996
Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications. Neurology, 1997, Volume: 48, Issue:2 Topics: Apomorphine; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Placebos; Receptors, Dopamine; Receptors, Presynaptic	1997
Opposite motor effects of pallidal stimulation in Parkinson's disease. Annals of neurology, 1998, Volume: 43, Issue:2 Topics: Apomorphine; Electric Stimulation Therapy; Electrodes, Implanted; Female; Follow-Up Studies; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Parkinson Disease; Stereotaxic Techniques; Treatment Outcome	1998
Effects of apomorphine on visual functions in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:1 Topics: Aged; Antiparkinson Agents; Apomorphine; Color Perception; Contrast Sensitivity; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Vision Disorders; Vision Tests	2000
Studies on the anti-dyskinesia effect of apomorphine in man. Neurologia, neurocirugia, psiquiatria, 1976, Volume: 17, Issue:4 Topics: Administration, Oral; Adult; Aged; Apomorphine; Clinical Trials as Topic; Drug Evaluation; Female; Haloperidol; Humans; Huntington Disease; Injections, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders	1976
Meige disease: striatal dopaminergic preponderance. Neurology, 1979, Volume: 29, Issue:8 Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos	1979
Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. The New England journal of medicine, 1976, Mar-11, Volume: 294, Issue:11 Topics: Administration, Oral; Aged; Apomorphine; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Growth Hormone; Humans; Kidney; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Secretory Rate	1976

Other Studies

76 other study(ies) available for apomorphine and Dyskinesia Syndromes

Article	Year
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents. Journal of medicinal chemistry, 1986, Volume: 29, Issue:9 Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri	1986
The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats. Behavioural brain research, 2014, Jun-01, Volume: 266 Topics: Adrenergic Agents; Animals; Apomorphine; Choline O-Acetyltransferase; Cognition Disorders; Corpus Striatum; Creatine; Interneurons; Male; Maze Learning; Medial Forebrain Bundle; Movement Disorders; Muscle Strength; Neuropeptide Y; Oxidopamine; Parvalbumins; Rats; Rats, Sprague-Dawley; Spatial Behavior; Tyrosine 3-Monooxygenase	2014
The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N(G)-nitro-L-arginine methyl ester administered alone or jointly with L-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats. Brain research, 2015, Nov-02, Volume: 1625 Topics: Adrenergic Agents; Animals; Apomorphine; Biogenic Monoamines; Brain; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Indazoles; Levodopa; Locomotion; Male; Movement Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Oxidopamine; Rats; Rats, Wistar; Time Factors	2015
Preventive effects of genistein on motor dysfunction following 6-hydroxydopamine injection in ovariectomized rats. Neuroscience letters, 2008, Dec-19, Volume: 448, Issue:1 Topics: Adrenergic Agents; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Genistein; Motor Activity; Movement Disorders; Neurons; Ovariectomy; Oxidopamine; Phytoestrogens; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase	2008
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nature neuroscience, 2009, Volume: 12, Issue:7 Topics: Age Factors; Animals; Antiparkinson Agents; Apomorphine; Brain; Chromosomes, Artificial, Bacterial; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Gene Transfer Techniques; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Mice; Mice, Transgenic; Movement Disorders; Mutation, Missense; Neurons; Nomifensine; Parkinson Disease; Protein Serine-Threonine Kinases	2009
Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note. Behavioural brain research, 2011, Sep-12, Volume: 222, Issue:1 Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Functional Laterality; Insecticides; Medial Forebrain Bundle; Movement; Movement Disorders; Neurons; Psychomotor Performance; Rats; Rats, Long-Evans; Rotenone; Stereotyped Behavior; Tyrosine 3-Monooxygenase	2011
Systemic treatment of focal brain injury in the rat by human umbilical cord blood cells being at different level of neural commitment. Acta neurobiologiae experimentalis, 2011, Volume: 71, Issue:1 Topics: Analysis of Variance; Animals; Antigens, CD34; Apomorphine; Brain Injuries; Cognition Disorders; Disease Models, Animal; Exploratory Behavior; Fetal Blood; Gene Expression Regulation; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intra-Arterial; Locomotion; Male; Movement Disorders; Nerve Tissue Proteins; Neurons; Neuropsychological Tests; Psychomotor Performance; Rats; Rats, Wistar; Recognition, Psychology; Rotation; Time Factors; Vibrissae	2011
Motor deficits and recovery in rats with unilateral spinal cord hemisection mimic the Brown-Sequard syndrome. Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 8 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Brown-Sequard Syndrome; Clonidine; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Female; Functional Laterality; Methoxamine; Motor Activity; Motor Neurons; Movement Disorders; Quipazine; Rats; Rats, Inbred Lew; Recovery of Function; Serotonin; Serotonin Receptor Agonists; Spinal Cord Injuries; Sympatholytics; Sympathomimetics; Tyrosine 3-Monooxygenase	2011
High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats. Behavioural brain research, 2013, Jan-15, Volume: 237 Topics: Acupuncture Points; Acupuncture Therapy; Analysis of Variance; Animals; Apomorphine; Biophysical Phenomena; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Gene Expression Regulation; Male; Movement Disorders; Neurons; Neurotoxicity Syndromes; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Sympatholytics	2013
Aquaporin-4 knockout abolishes apomorphine-induced tardive dyskinesia following chronic treatment with neuroleptics. CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:12 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Aquaporin 4; Clozapine; Corpus Striatum; Disease Models, Animal; Glial Fibrillary Acidic Protein; Haloperidol; Hippocampus; Male; Mastication; Mice; Mice, Knockout; Motor Activity; Movement Disorders	2012
Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiology of disease, 2003, Volume: 14, Issue:3 Topics: Adenoviridae; Animals; Apomorphine; Cell Death; Cell Survival; Corpus Striatum; Disease Models, Animal; Gene Transfer Techniques; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Infarction, Middle Cerebral Artery; Lentivirus; Male; Movement Disorders; Nerve Degeneration; Nerve Growth Factors; Rats; Rats, Wistar; Stroke; Transduction, Genetic; Treatment Failure; Up-Regulation	2003
Amyloid beta protein impairs motor function via thromboxane A2 in the rat striatum. Neurobiology of disease, 2004, Volume: 16, Issue:3 Topics: Amyloid beta-Peptides; Animals; Apomorphine; Corpus Striatum; Dopamine Agonists; Locomotion; Male; Motor Neurons; Movement Disorders; Peptide Fragments; Rats; Rats, Wistar; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2	2004
Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse (New York, N.Y.), 2004, Dec-01, Volume: 54, Issue:3 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding Sites; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Electron Spin Resonance Spectroscopy; Haloperidol; Humans; Male; Mastication; Motor Activity; Movement Disorders; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine D2	2004
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Feb-23, Volume: 25, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Mice; Mice, Knockout; Movement Disorders; Parkinson Disease; Patch-Clamp Techniques; Protein Interaction Mapping; Protein Structure, Tertiary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reserpine; RGS Proteins; Subcellular Fractions; Sulpiride; Transfection	2005
Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. Brain research, 2006, Sep-27, Volume: 1112, Issue:1 Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Benzazepines; Brain Injuries; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Isoindoles; Male; Movement Disorders; Oxidopamine; Piperazines; Pyridines; Pyrimidines; Rats; Rats, Wistar; Rotarod Performance Test; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	2006
Experimental dyskinesias of the jaw: central and oral induction of the periodontal-masseteric reflex in the rat. Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia, 1984, Volume: 80 Suppl 9-11 Topics: Animals; Antipsychotic Agents; Apomorphine; Bruxism; Hypnotics and Sedatives; Male; Masticatory Muscles; Movement Disorders; Muscle Relaxants, Central; Muscle Tonus; Nerve Degeneration; Periodontium; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reflex; Sensation; Serotonin; Substance P	1984
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology, 1980, Volume: 69, Issue:1 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Mouth Diseases; Movement Disorders; Occipital Lobe; Rats; Substance Withdrawal Syndrome	1980
Biphasic effect of estradiol and domperidone on lingual dyskinesia in monkeys. Experimental neurology, 1983, Volume: 82, Issue:1 Topics: Animals; Apomorphine; Domperidone; Dose-Response Relationship, Drug; Estradiol; Female; Macaca fascicularis; Movement Disorders; Time Factors; Tongue Diseases	1983
Antidyskinetic properties of estrogens. Bollettino della Societa italiana di biologia sperimentale, 1983, Jan-31, Volume: 59, Issue:2 Topics: Animals; Apomorphine; Catalepsy; Estradiol; Estrogens; Glutamate Decarboxylase; Haloperidol; Humans; Male; Motor Activity; Movement Disorders; Rats; Rats, Inbred Strains	1983
Induction of wet-dog shakes by intracerebral 'acid' TRH in rats. Neuroscience letters, 1980, Volume: 16, Issue:2 Topics: Animals; Apomorphine; Cyproheptadine; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Movement Disorders; Naloxone; Phentolamine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone	1980
[Apomorphine in dyskinesia and psychomotor agitation]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1982, Volume: 82, Issue:8 Topics: Adolescent; Adult; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Movement Disorders; Psychomotor Agitation; Schizophrenia	1982
"On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment. Acta neurologica Scandinavica, 1982, Volume: 66, Issue:2 Topics: Apomorphine; Dystonia; Ergolines; Evaluation Studies as Topic; Female; Humans; Lisuride; Male; Middle Aged; Movement Disorders	1982
[Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists]. Revue neurologique, 1982, Volume: 138, Issue:5 Topics: Aged; Apomorphine; Basal Ganglia Diseases; Dopamine Antagonists; Drug Therapy, Combination; Female; Humans; Movement Disorders; Receptors, Dopamine	1982
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1995, Volume: 15, Issue:5 Pt 2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Carbidopa; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Agonists; Ergolines; Female; Fetal Tissue Transplantation; Forelimb; Functional Laterality; Levodopa; Motor Activity; Movement Disorders; Norepinephrine; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Transplantation, Heterotopic	1995
PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates. Experimental neurology, 1994, Volume: 125, Issue:1 Topics: Acetylcholinesterase; Animals; Apomorphine; Behavior, Animal; Caudate Nucleus; Dopamine; Glucose; Hemodynamics; Macaca fascicularis; Macaca mulatta; Magnetic Resonance Imaging; Movement Disorders; Nerve Endings; Putamen; Quinolinic Acid; Receptors, Dopamine; Tomography, Emission-Computed; Tyrosine 3-Monooxygenase	1994
[Akinetic crisis in Parkinson disease]. Schweizerische medizinische Wochenschrift, 1994, Jun-11, Volume: 124, Issue:23 Topics: Aged; Aged, 80 and over; Apomorphine; Benserazide; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1994
The neuronal mechanism underlying parkinsonism and dyskinesia, and differential roles of the putamen and caudate nucleus. Advances in neurology, 1993, Volume: 60 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bicuculline; Cats; Caudate Nucleus; Globus Pallidus; Injections, Subcutaneous; Macaca; Motor Skills; Movement Disorders; Neural Pathways; Neurons; Parkinson Disease, Secondary; Picrotoxin; Putamen; Rats; Rats, Wistar; Synaptic Transmission	1993
Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine. Advances in neurology, 1993, Volume: 60 Topics: Aged; Apomorphine; Brain; Dopamine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Activity; Motor Cortex; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Regional Blood Flow; Somatosensory Cortex; Tomography, Emission-Computed, Single-Photon	1993
Behavioral and neurochemical dysfunction in the circling (ci) rat: a novel genetic animal model of a movement disorder. Neuroscience, 1996, Volume: 74, Issue:4 Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Agonists; Female; Forelimb; Male; Motor Activity; Motor Skills; Movement Disorders; Mutation; Rats; Rats, Inbred Lew; Stereotyped Behavior	1996
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats. Experimental neurology, 1997, Volume: 145, Issue:1 Topics: Administration, Oral; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Cell Transplantation; Disease Models, Animal; Dopamine; Drug Combinations; Drug Synergism; Levodopa; Male; Movement Disorders; Neostriatum; Parkinson Disease, Secondary; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotation	1997
Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration. Experimental neurology, 1997, Volume: 146, Issue:1 Topics: Acetylcholinesterase; Animals; Antiparkinson Agents; Apomorphine; Caudate Nucleus; Corpus Striatum; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Papio; Parkinson Disease, Secondary; Propionates; Putamen; Riluzole; Thiazoles	1997
Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats. Experimental neurology, 1997, Volume: 147, Issue:2 Topics: Animals; Animals, Newborn; Apomorphine; Brain Damage, Chronic; Brain Ischemia; Brain Tissue Transplantation; Fetal Hypoxia; Fetal Tissue Transplantation; Hypoxia, Brain; Movement Disorders; Neocortex; Nerve Degeneration; Psychomotor Performance; Rats; Rats, Wistar; Sensation Disorders; Stereotyped Behavior	1997
Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Annals of neurology, 1997, Volume: 42, Issue:5 Topics: Action Potentials; Aged; Antiparkinson Agents; Apomorphine; Electrophysiology; Globus Pallidus; Humans; Male; Movement Disorders; Neurons; Parkinson Disease	1997
[Subcutaneous apomorphine in Parkinson disease]. Revista medica de Chile, 1996, Volume: 124, Issue:11 Topics: Aged; Apomorphine; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Movement Disorders; Parkinson Disease	1996
Parkinson's disease and lower limb somatosensory evoked potentials: apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials. Journal of the neurological sciences, 1999, Apr-01, Volume: 164, Issue:2 Topics: Aged; Antiparkinson Agents; Apomorphine; Brain Stem; Electrophysiology; Evoked Potentials, Somatosensory; Female; Humans; Leg; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Syndrome	1999
Synthesis and preliminary pharmacological evaluation of thiophene analogues of viloxazine as potential antidepressant drugs. Bioorganic & medicinal chemistry, 1999, Volume: 7, Issue:7 Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Dose-Response Relationship, Drug; Female; Hypothermia; Imipramine; Lethal Dose 50; Male; Mice; Movement Disorders; Pentobarbital; Sleep; Structure-Activity Relationship; Tetrabenazine; Viloxazine	1999
Locomotor and learning deficits in adult rats exposed to monosodium-L-glutamate during early life. Neuroscience letters, 2000, Apr-21, Volume: 284, Issue:1-2 Topics: Age Factors; Animals; Apomorphine; Brain; Dopamine Agonists; Learning Disabilities; Male; Movement Disorders; Neurons; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Sodium Glutamate; Weaning	2000
Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia, 1976, Feb-02, Volume: 45, Issue:3 Topics: Amphetamines; Animals; Apomorphine; Brain; Cats; Caudate Nucleus; Corpus Striatum; Dopamine; Electrophysiology; Ergot Alkaloids; gamma-Aminobutyric Acid; Humans; Movement Disorders; Neural Inhibition; Piribedil; Rats; Receptors, Drug; Receptors, Neurotransmitter; Septal Nuclei; Substantia Nigra; Synaptic Transmission	1976
Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain : a journal of neurology, 1977, Volume: 100, Issue:2 Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents	1977
Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science (New York, N.Y.), 1979, Oct-26, Volume: 206, Issue:4417 Topics: Aging; Animals; Apomorphine; Levodopa; Male; Movement Disorders; Rats; Receptors, Dopamine; Swimming; Time Factors	1979
Role of the caudate nucleus in production of dyskinesia [proceedings]. Applied neurophysiology, 1979, Volume: 42, Issue:5 Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; Electric Stimulation; Levodopa; Movement Disorders; Neural Pathways; Substantia Nigra; Tremor	1979
[Effect of phosphodiesterase inhibitors on neuroleptic-induced catalepsy and apomorphine-induced stereotypic movements in rats]. Bollettino della Societa italiana di biologia sperimentale, 1978, Apr-30, Volume: 54, Issue:8 Topics: Animals; Apomorphine; Atropine; Catalepsy; Haloperidol; Humans; Movement Disorders; Papaverine; Phosphodiesterase Inhibitors; Rats	1978
Effect of haloperidol on reflex activation of rat alpha-motoneurones. A possible explanation for akinesia and catalepsy? Naunyn-Schmiedeberg's archives of pharmacology, 1979, Volume: 308, Issue:2 Topics: Animals; Apomorphine; Catalepsy; Haloperidol; Humans; In Vitro Techniques; Male; Motor Neurons; Movement Disorders; Rats; Reflex; Time Factors	1979
Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias. European journal of pharmacology, 1976, Volume: 36, Issue:2 Topics: Animals; Apomorphine; Behavior; Dextroamphetamine; Dopamine; Guinea Pigs; Humans; Male; Movement Disorders; Stereotyped Behavior; Tranquilizing Agents	1976
[Nigrostiatally induced motor reactions in the rat. II. Cholinergic effect on rotational behavior and posture asymetry]. Acta biologica et medica Germanica, 1976, Volume: 35, Issue:6 Topics: Apomorphine; Carbachol; Caudate Nucleus; Hydroxydopamines; Movement Disorders; Oxotremorine; Posture; Receptors, Cholinergic; Receptors, Dopamine	1976
[Nigrostriatally induced motor reactions in the rat. I. Rotational behavior and posture asymetry after intracerebral injection of apomorphine and dopamine]. Acta biologica et medica Germanica, 1976, Volume: 35, Issue:6 Topics: Animals; Apomorphine; Ascorbic Acid; Brain; Caudate Nucleus; Dopamine; Female; Haloperidol; Hydroxydopamines; Injections; Movement Disorders; Posture; Rats; Receptors, Dopamine	1976
[Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)]. Arzneimittel-Forschung, 1976, Volume: 26, Issue:6 Topics: Animals; Apomorphine; Atropine; Clozapine; Corpus Striatum; Dibenzazepines; Dopamine; Drug Synergism; Haloperidol; Humans; Movement Disorders; Rats; Receptors, Drug; Stereotyped Behavior	1976
Screening hallucinogenic drugs: systematic study of three behavioral tests. Psychopharmacologia, 1975, May-28, Volume: 42, Issue:2 Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Arousal; Behavior, Animal; Chlorpromazine; Diazepam; Drug Evaluation, Preclinical; Grooming; Hallucinogens; Head; Male; Mice; Morphine; Motor Activity; Movement Disorders; Pentobarbital; Rats; Reinforcement Schedule; Reinforcement, Psychology; Research Design	1975
Role of the strio-pallidal system and motor cortex in induced circus movements in rats and cats. Experimental neurology, 1975, Volume: 47, Issue:1 Topics: Animals; Apomorphine; Brain Mapping; Cats; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Levodopa; Locomotion; Male; Mesencephalon; Motor Cortex; Movement Disorders; Neural Pathways; Rats	1975
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders. Archives of general psychiatry, 1975, Volume: 32, Issue:6 Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders	1975
Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias. Advances in neurology, 1975, Volume: 9 Topics: Amphetamine; Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Guinea Pigs; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Receptors, Drug; Stereotyped Behavior; Time Factors	1975
Actions of dopaminergic agonists on motor function. Advances in neurology, 1975, Volume: 9 Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Antagonists; Humans; Hyperkinesis; Levodopa; Methylphenidate; Motor Activity; Movement Disorders; Phenethylamines; Piribedil; Rats; Stereotyped Behavior; Tyrosine	1975
Apomorphine and piribedil in rats: biochemical and pharmacologic studies. Advances in neurology, 1975, Volume: 9 Topics: Amygdala; Animals; Apomorphine; Behavior; Brain; Corpus Striatum; Drug Synergism; Hippocampus; Humans; Hypothalamus; Movement Disorders; Olfactory Bulb; Piperazines; Piribedil; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior	1975
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia, 1975, Volume: 41, Issue:2 Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; Disease Models, Animal; Dopamine; Drug Tolerance; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Movement Disorders; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome	1975
Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration. Journal of the neurological sciences, 1975, Volume: 25, Issue:3 Topics: Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine; Humans; Levodopa; Male; Mice; Movement Disorders; Parkinson Disease; Receptors, Drug; Stereotyped Behavior; Time Factors	1975
[Animal stereotypy and transmethylation of cerebral amines]. Bollettino della Societa italiana di biologia sperimentale, 1975, Apr-15, Volume: 51, Issue:7 Topics: Amines; Amphetamine; Animals; Apomorphine; Brain; Levodopa; Movement Disorders; Piribedil; Rats; S-Adenosylmethionine	1975
Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Brain research, 1975, Dec-12, Volume: 100, Issue:1 Topics: Animals; Apomorphine; Caudate Nucleus; Corpus Striatum; Dextroamphetamine; Dopamine; Humans; Male; Movement Disorders; Occipital Lobe; Rats; Septal Nuclei; Stereotyped Behavior; Substantia Nigra	1975
[Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease]. Revue neurologique, 1992, Volume: 148, Issue:10 Topics: Administration, Sublingual; Adult; Aged; Apomorphine; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease	1992
Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:11 Topics: Adult; Apomorphine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1992
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Annals of neurology, 1992, Volume: 32, Issue:6 Topics: Adult; Aged; Apomorphine; Brain; Cerebral Cortex; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychomotor Performance; Tomography, Emission-Computed	1992
[Subcutaneous apomorphine in major motor oscillations of parkinsonian patients]. Presse medicale (Paris, France : 1983), 1992, Feb-01, Volume: 21, Issue:4 Topics: Aged; Apomorphine; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Male; Middle Aged; Movement Disorders; Parkinson Disease	1992
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations. Clinical neuropharmacology, 1991, Volume: 14, Issue:6 Topics: Administration, Sublingual; Adult; Apomorphine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pilot Projects	1991
Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:3 Topics: Administration, Oral; Adult; Aged; Apomorphine; Drug Tolerance; Ergolines; Humans; Infusion Pumps; Levodopa; Lisuride; Middle Aged; Movement Disorders; Parkinson Disease	1990
Induction of dyskinesias. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:3 Topics: Animals; Apomorphine; Delayed-Action Preparations; Levodopa; Movement Disorders; Parkinson Disease; Rats; Receptors, Dopamine	1990
Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction. Psychopharmacology, 1989, Volume: 97, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Avoidance Learning; Buspirone; Dopamine; Haloperidol; Male; Movement Disorders; Pyrimidinones; Saimiri; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes	1989
Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Journal of the neurological sciences, 1989, Volume: 90, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Dose-Response Relationship, Drug; Ergolines; Injections, Intravenous; Levodopa; Macaca fascicularis; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Quinpirole; Stereotyped Behavior	1989
Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients. Lancet (London, England), 1972, Nov-04, Volume: 2, Issue:7784 Topics: Adult; Apomorphine; Haloperidol; Humans; Male; Movement Disorders; Schizophrenia	1972
Functional recovery after lesions of the nervous system. IV. Structural correlates of recovery in adult subjects. Changes in drug sensitivity during recovery of function after brain damage. Neurosciences Research Program bulletin, 1974, Volume: 12, Issue:2 Topics: Amphetamine; Animals; Apomorphine; Brain; Brain Injuries; Brain Mapping; Corpus Striatum; Frontal Lobe; Locomotion; Movement Disorders; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Rats; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase	1974
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta physiologica Scandinavica. Supplementum, 1971, Volume: 367 Topics: Amphetamine; Animals; Apomorphine; Brain; Butyrophenones; Dopamine; Electrocoagulation; Haloperidol; Histological Techniques; Male; Mixed Function Oxygenases; Movement Disorders; Nerve Degeneration; Nialamide; Norepinephrine; Posture; Rats; Reserpine; Rotation; Stereotaxic Techniques; Substantia Nigra; Synaptic Transmission; Time Factors	1971
Drug-induced syndromes in rats with large, chronic lesions in the corpus striatum. Psychopharmacologia, 1972, Volume: 27, Issue:2 Topics: Amphetamine; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Brain; Globus Pallidus; Haloperidol; Movement Disorders; Rats; Reserpine; Synaptic Transmission	1972
Unexpected findings with apomorphine and their possible consequences. Advances in neurology, 1974, Volume: 5 Topics: Administration, Oral; Antiparkinson Agents; Apomorphine; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Movement Disorders; Parkinson Disease; Structure-Activity Relationship; Uremia	1974
Short- and long-term approaches to the "on-off" phenomenon. Advances in neurology, 1974, Volume: 5 Topics: Apomorphine; Carbidopa; Dietary Proteins; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Time Factors	1974
Levodopa, manganese, and degenerations of the brain. Harvey lectures, 1974, Volume: 68 Topics: Administration, Oral; Animals; Apomorphine; Blood Urea Nitrogen; Brain Diseases; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chronic Disease; Dietary Proteins; Dopamine; Drug Therapy, Combination; Growth Hormone; Humans; Injections; Levodopa; Manganese Poisoning; Movement Disorders; Neutron Activation Analysis; Parkinson Disease; Psychoses, Substance-Induced; Radioisotopes	1974
An experimental model of tardive dyskinesia. Journal of neural transmission, 1972, Volume: 33, Issue:3 Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Movement Disorders; Stereotyped Behavior	1972
Levodopa and related drugs. The Medical letter on drugs and therapeutics, 1973, Mar-02, Volume: 15, Issue:5 Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine	1973
Melatonin and abnormal movements induced by L-dopa in mice. Science (New York, N.Y.), 1971, Jul-30, Volume: 173, Issue:3995 Topics: Administration, Oral; Animals; Apomorphine; Brain Chemistry; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Drug Antagonism; Injections, Intraperitoneal; Lethal Dose 50; Male; Melanocyte-Stimulating Hormones; Mice; Movement Disorders; Serotonin; Time Factors	1971